{"id":"https://openalex.org/W4405374550","doi":"https://doi.org/10.1016/j.iotech.2024.100856","title":"113P Clinical outcomes of avelumab and pembrolizumab in advanced urothelial cancer: An observational multicenter retro-prospective study on patients undergoing treatment in clinical practice (AVePEm study)","display_name":"113P Clinical outcomes of avelumab and pembrolizumab in advanced urothelial cancer: An observational multicenter retro-prospective study on patients undergoing treatment in clinical practice (AVePEm study)","alternate_titles":[],"publication_year":2024,"publication_date":"2024-12-01","ids":{"openalex":"https://openalex.org/W4405374550","doi":"https://doi.org/10.1016/j.iotech.2024.100856"},"language":"en","primary_location":{"id":"doi:10.1016/j.iotech.2024.100856","doi":"https://doi.org/10.1016/j.iotech.2024.100856","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2024.100856","pdf_url":"https://www.esmoiotech.org/article/S2590-0188(24)00153-9/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4405374550"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.esmoiotech.org/article/S2590-0188(24)00153-9/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092083411","display_name":"Irene Torresan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]},{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"I. Torresan","raw_affiliation_strings":["Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy","institution_ids":["https://openalex.org/I119439378","https://openalex.org/I4210094363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034124811","display_name":"Anna Sordo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Sordo","raw_affiliation_strings":["Centro Ricerche Cliniche di Verona - CRC, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Ricerche Cliniche di Verona - CRC, Verona, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"C. Lorenzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]},{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C. Lorenzi","raw_affiliation_strings":["Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy","institution_ids":["https://openalex.org/I119439378","https://openalex.org/I4210094363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005499943","display_name":"Sara Merler","orcid":"https://orcid.org/0000-0002-8691-6284","observed_orcids":["https://orcid.org/0000-0002-8691-6284"]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]},{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Merler","raw_affiliation_strings":["Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy","institution_ids":["https://openalex.org/I119439378","https://openalex.org/I4210094363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115434151","display_name":"Ester Tasselli","orcid":"https://orcid.org/0009-0000-1267-8001","observed_orcids":["https://orcid.org/0009-0000-1267-8001"]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]},{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E. Tasselli","raw_affiliation_strings":["Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy","institution_ids":["https://openalex.org/I119439378","https://openalex.org/I4210094363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018967074","display_name":"Sarah Pafumi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]},{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S. Pafumi","raw_affiliation_strings":["Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy","institution_ids":["https://openalex.org/I119439378","https://openalex.org/I4210094363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069797469","display_name":"Silvia Palmerio","orcid":"https://orcid.org/0000-0001-8874-3711","observed_orcids":["https://orcid.org/0000-0001-8874-3711"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Palmerio","raw_affiliation_strings":["Centro Ricerche Cliniche di Verona - CRC, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Ricerche Cliniche di Verona - CRC, Verona, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024050916","display_name":"Emilia Durante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162221","display_name":"Azienda Ospedaliera Ospedale Civile di Legnano","ror":"https://ror.org/046w0kr18","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210162221"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E. Durante","raw_affiliation_strings":["Oncology, Mater Salutis Hospital Legnano, Legnago, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Mater Salutis Hospital Legnano, Legnago, Italy","institution_ids":["https://openalex.org/I4210162221"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043631669","display_name":"Nicola Inzerilli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267178","display_name":"Ospedale P. Pederzoli \u2013 Casa di Cura Privata S.p.a.","ror":"https://ror.org/01hkgkp28","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4405267178"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"N. Inzerilli","raw_affiliation_strings":["Oncology, Pederzoli Hospital, Peschiera del Garda, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Pederzoli Hospital, Peschiera del Garda, Italy","institution_ids":["https://openalex.org/I4405267178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083145348","display_name":"Mattia Pellicciari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267178","display_name":"Ospedale P. Pederzoli \u2013 Casa di Cura Privata S.p.a.","ror":"https://ror.org/01hkgkp28","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4405267178"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Pellicciari","raw_affiliation_strings":["Oncology, Pederzoli Hospital, Peschiera del Garda, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Pederzoli Hospital, Peschiera del Garda, Italy","institution_ids":["https://openalex.org/I4405267178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011805898","display_name":"Davide Pastorelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267178","display_name":"Ospedale P. Pederzoli \u2013 Casa di Cura Privata S.p.a.","ror":"https://ror.org/01hkgkp28","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4405267178"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"D. Pastorelli","raw_affiliation_strings":["Oncology, Pederzoli Hospital, Peschiera del Garda, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Pederzoli Hospital, Peschiera del Garda, Italy","institution_ids":["https://openalex.org/I4405267178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045403152","display_name":"M. Milella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]},{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Milella","raw_affiliation_strings":["Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy","institution_ids":["https://openalex.org/I119439378","https://openalex.org/I4210094363"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107870578","display_name":"Andrea Zivi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]},{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Zivi","raw_affiliation_strings":["Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy","institution_ids":["https://openalex.org/I119439378","https://openalex.org/I4210094363"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071372725","display_name":"Francesca Zacchi","orcid":"https://orcid.org/0000-0002-7448-7822","observed_orcids":["https://orcid.org/0000-0002-7448-7822"]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]},{"id":"https://openalex.org/I4210094363","display_name":"Azienda Ospedaliera Universitaria Integrata Verona","ror":"https://ror.org/00sm8k518","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094363"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Zacchi","raw_affiliation_strings":["Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy","institution_ids":["https://openalex.org/I119439378","https://openalex.org/I4210094363"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3170,"currency":"USD","value_usd":3170},"apc_paid":{"value":3170,"currency":"USD","value_usd":3170},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":null,"first_page":"100856","last_page":"100856"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.03519999980926514,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/avelumab","display_name":"avelumab","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/metastatic-urothelial-carcinoma","display_name":"metastatic urothelial carcinoma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6589999794960022},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8059999942779541},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8119999766349792},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.7110000252723694},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C2777381376","wikidata":"https://www.wikidata.org/wiki/Q21083261","display_name":"Avelumab","level":5,"score":0.8558604717254639},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8215099573135376},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7652261853218079},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7210706472396851},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.5270372033119202},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47205525636672974},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43565836548805237},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3326994776725769},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2548820972442627},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.18699213862419128}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.iotech.2024.100856","doi":"https://doi.org/10.1016/j.iotech.2024.100856","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2024.100856","pdf_url":"https://www.esmoiotech.org/article/S2590-0188(24)00153-9/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.iotech.2024.100856","doi":"https://doi.org/10.1016/j.iotech.2024.100856","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.iotech.2024.100856","pdf_url":"https://www.esmoiotech.org/article/S2590-0188(24)00153-9/pdf","source":{"id":"https://openalex.org/S4210240197","display_name":"Immuno-Oncology Technology","issn_l":"2590-0188","issn":["2590-0188"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immuno-Oncology and Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405374550.pdf","grobid_xml":"https://content.openalex.org/works/W4405374550.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4407830526","https://openalex.org/W4388160522","https://openalex.org/W4388160983","https://openalex.org/W3111698003","https://openalex.org/W4245854978","https://openalex.org/W4388160530","https://openalex.org/W4388159742","https://openalex.org/W4404144201","https://openalex.org/W4404143848","https://openalex.org/W4254491264"],"abstract_inverted_index":{"Patients":[0],"(pts)":[1],"with":[2,28],"metastatic":[3],"urothelial":[4],"carcinoma":[5],"(mUC)":[6],"who":[7],"do":[8],"not":[9],"experience":[10],"disease":[11],"progression":[12],"after":[13],"4-6":[14],"cycles":[15],"of":[16],"first-line":[17],"platinum-based":[18],"chemotherapy":[19],"(PBC)":[20],"may":[21],"benefit":[22],"from":[23],"immunotherapy":[24],"as":[25,33],"maintenance":[26],"treatment":[27],"Avelumab,":[29],"or":[30],"receive":[31],"Pembrolizumab":[32],"a":[34],"second-line.":[35]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4405374550","counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2024-12-14T00:00:00"}
